Aneurysmal subarachnoid hemorrhage (aSAH) represents a critical neurovascular emergency associated with substantial morbidity and mortality worldwide. Accurate early risk stratification is vital for tailoring intensive care, guiding surgical interventions, and discussing realistic prognoses with families. Clinicians traditionally rely on established grading systems such as the Hunt and Hess classification and the World Federation of Neurosurgical Societies (WFNS) scale. However, investigators recently developed the HATCH score to provide a more comprehensive prognostic assessment by integrating hemorrhage volume, age, treatment modality, clinical condition, and hydrocephalus. A newly published multicenter study from Argentina has evaluated the external validity and calibration of the HATCH score in a middle-income cohort, offering essential insights for global critical care and neurology teams.

Rationale and Components of the HATCH Score

Risk prediction in neurocritical care requires models that capture both physiological vulnerability and anatomical injury severity. The HATCH score addresses these complex dynamics by synthesizing five crucial prognostic determinants into a practical bedside tool. Specifically, the acronym represents Hemorrhage extent based on radiological grading, patient Age, aneurysm Treatment strategy (surgical clipping versus endovascular coiling), initial Clinical state measured by the Glasgow Coma Scale, and the presence of acute Hydrocephalus requiring cerebrospinal fluid diversion. Furthermore, each variable contributes weighted points to generate a cumulative risk profile. Therefore, clinicians obtain a multidimensional perspective that reflects acute neurological disruption alongside structural brain pathology. In contrast, traditional scoring systems frequently focus solely on admission consciousness or clinical symptoms, potentially overlooking radiographic nuances and therapeutic modifiers that heavily influence long-term functional recovery.

Study Design and Patient Cohort Characteristics

The external validation investigation involved a retrospective multicenter cohort study conducted across three tertiary hospitals in Argentina between 2011 and 2024. Researchers analyzed consecutive adult patients diagnosed with aSAH who required admission to the intensive care unit. Overall, the final analysis included 177 patients with documented baseline clinical and radiographic variables. The primary outcome was functional neurological status at 6 months, categorized using the modified Rankin Scale (mRS) into favorable recovery (mRS 0 to 3) versus poor outcome or severe disability (mRS 4 to 6). Additionally, the secondary endpoint evaluated all-cause mortality at 12 months post-ictus. Statistical analysis rigorously assessed both discrimination using the Area Under the Receiver Operating Characteristic curve (AUROC) via DeLong tests and calibration through calibration-in-the-large (CITL) and calibration slope metrics derived from the original development models.

Comparative Discrimination and Calibration Findings

In the primary analysis, 57% of patients achieved a favorable functional recovery at 6 months. When evaluating discrimination for 6-month functional status, the HATCH score demonstrated strong predictive ability with an AUROC of 0.80 (95% CI 0.73–0.86). This performance was statistically comparable to the Hunt-Hess scale (AUROC 0.79, 95% CI 0.72–0.86) and the WFNS scale (AUROC 0.81, 95% CI 0.74–0.87, p = 0.44). However, substantial differences emerged during calibration analysis across the models. The HATCH score displayed excellent agreement across risk probabilities with a calibration slope of 0.94 (95% CI 0.64–1.24) and mild underprediction (CITL 0.61). Conversely, the Hunt-Hess scale overpredicted poor outcomes (CITL -0.58) and suffered from poor risk agreement (slope 0.47). Meanwhile, WFNS maintained a robust slope (1.19) but demonstrated systematic underprediction (CITL 1.62). Consequently, the HATCH tool offered superior balance between discrimination and calibration for mid-term functional recovery.

Long-Term Mortality Stratification at Twelve Months

Evaluating secondary endpoints revealed distinct predictive characteristics when forecasting 12-month mortality. All three scoring tools exhibited moderate discriminative power, yielding an AUROC of 0.72 (95% CI 0.64–0.79) for the HATCH score, 0.69 (95% CI 0.61–0.77) for Hunt-Hess, and 0.73 (95% CI 0.66–0.81) for the WFNS scale without significant statistical divergence (p = 0.12). Nevertheless, calibration trajectories varied substantially among the models over this extended follow-up window. In this setting, WFNS demonstrated the most stable calibration performance, yielding a slope of 0.87 (95% CI 0.52–1.23) and a CITL of 0.74. In comparison, the HATCH score showed a calibration slope of 0.55 and a CITL of -0.36, while the Hunt-Hess scale demonstrated marked miscalibration. Therefore, while HATCH excels in functional forecasting, WFNS remains highly dependable for long-term survival estimation.

Clinical Implications for Critical Care and Resource Allocation

Applying validated predictive models is especially crucial in resource-constrained environments, including low- and middle-income healthcare systems. Clinical teams often face challenging decisions regarding intensive monitoring, mechanical ventilation duration, and timing of aggressive neurosurgical interventions. Because the HATCH score accounts for treatment modalities and acute hydrocephalus alongside neurological status, it equips intensivists with granular prognostic data. Moreover, accurate calibration prevents inappropriate therapeutic pessimism or unwarranted withdrawal of life-sustaining treatment in patients with salvageable functional potential. Clinicians should nevertheless remember that prognostic scores serve as supportive adjuncts rather than deterministic instruments. Incorporating multidisciplinary assessments, dynamic neurological tracking, and serial neuroimaging remains fundamental when managing acute aneurysmal subarachnoid hemorrhage.

Frequently Asked Questions

What clinical components comprise the HATCH score in aneurysmal subarachnoid hemorrhage?

The HATCH score incorporates five clinical and radiological variables: Hemorrhage volume determined by neuroimaging, patient Age, aneurysm Treatment modality, baseline Clinical status via the Glasgow Coma Scale, and acute Hydrocephalus. These variables combine to create an objective, multi-parameter risk profile for functional outcome forecasting.

How does the HATCH score compare to Hunt-Hess and WFNS scales for functional outcomes?

The HATCH score demonstrates equivalent discrimination (AUROC 0.80) to Hunt-Hess and WFNS scales for 6-month functional outcomes. Crucially, however, HATCH offers superior calibration balance across probability spectrums, avoiding the severe overprediction observed with Hunt-Hess and the systematic underprediction seen with WFNS.

Can the HATCH score reliably predict 12-month mortality after subarachnoid hemorrhage?

The HATCH score provides moderate discrimination for 12-month mortality (AUROC 0.72). However, for long-term mortality specifically, the WFNS scale demonstrates more stable calibration metrics. Clinicians often combine both scoring systems to optimize individual risk assessment across short-term functional recovery and extended survival.

Disclaimer: This content is for informational and educational purposes only and does not substitute professional medical advice, diagnosis, or treatment. Always consult qualified healthcare providers with any questions regarding medical conditions. Refer to the latest local and national guidelines for clinical practice.

References

1. Gonzalez MV et al. Validation of HATCH score to predict neurological outcome in patients with aneurysmal subarachnoid hemorrhage in a Latin American middle-income country. Neurosurg Rev. 2026 Aug 19. doi: 10.1007/s10143-026-04448-x. PMID: 42613490.


2. Hostettler IC, Sebök M, Ambler G, et al. Validation and Optimization of Barrow Neurological Institute Score in Prediction of Adverse Events and Functional Outcome After Subarachnoid Hemorrhage—Creation of the HATCH (Hemorrhage, Age, Treatment, Clinical State, Hydrocephalus) Score. Neurosurgery. 2021;88(1):96-105.


3. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988;51(11):1457.